Last December, Invitrogen CEO Greg Lucier told analysts to "think India for research."
Clearly, Invitrogen is. The Carlsbad, Calif., company has named Uday Matrubutham, a senior scientist of Indian extraction, as associate director of R&D. He has moved to Bangalore to manage a research and development facility that is expected to become operational this month. The facility will employ 20 scientists for research in functional genomics and bioinformatics, the company said. Further details were not available.